Clinical trial
Thalidomide to Patients With Previously Untreated Multiple Myeloma
NCT00218855 · Norwegian University of Science and Technology, Other · Completed
Key facts
| NCT number | NCT00218855 |
|---|---|
| Title | Thalidomide to Patients With Previously Untreated Multiple Myeloma |
| Official title | A Phase 3 Study With Randomization to Melphalan/Prednisone/Thalidomide Versus Melphalan/Prednisone/Placebo to Patients With Previously Untreated Multiple Myeloma |
| Lead sponsor | Norwegian University of Science and Technology, Other |
| Collaborators | The Research Council of Norway Nordic Myeloma Study Group, Germany |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | thalidomide, placebo |
| Enrollment | 363 |
| Start date | Jan 1, 2002 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 7, 2014 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: